• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物在稳定表达δ阿片受体的C6胶质瘤细胞系中的疗效。

Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.

作者信息

Clark M J, Emmerson P J, Mansour A, Akil H, Woods J H, Portoghese P S, Remmers A E, Medzihradsky F

机构信息

Department of Pharmacology,University of Michigan, Ann Arbor, Michigan 48109-0632, USA.

出版信息

J Pharmacol Exp Ther. 1997 Nov;283(2):501-10.

PMID:9353363
Abstract

A C6 glioma cell line stably transfected with the rat delta opioid receptor (C6delta) was used to characterize receptor binding and G protein activation by both peptide and nonpeptide delta opioid ligands. The ligand binding affinities for [3H]naltrindole and [3H]pCl-[D-Pen2,D-Pen5]enkephalin (DPDPE) were similar to those observed in monkey brain membranes. The nonpeptide agonists, BW373U86 and SNC80, as well as peptide agonist [D-Ser2, L-Leu5]enkephalyl-Thr maximally stimulated [35S]GTPgammaS binding by 640, 654 and 576%, respectively, over basal. The peptide agonists, DPDPE and deltorphin II, both stimulated [35S]GTPgammaS binding by 375%. Etorphine, diprenorphine, oxymorphindole and 7-spiroindanyloxymorphone were also partial agonists in this assay, although they were less efficacious than deltorphin II. Stimulation of [35S]GTPgammaS binding by agonists was blocked completely by pertussis toxin pretreatment. Both delta-1 and delta-2 selective antagonists 7-benzylidenenaltrexone and a benzofuran analog of naltrindole displayed high affinity for the cloned receptor (0.04 and 0.08 nM) and antagonized the stimulation of [35S]GTPgammaS binding by BW373U86 and DPDPE with similar potencies. Other evidence suggesting the lack of receptor subtypes includes the finding that stimulation of [35S]GTPgammaS binding by receptor subtype selective ligands DPDPE and deltorphin II was not additive. BW373U86, SNC80 and DPDPE maximally inhibited forskolin-stimulated adenylyl cyclase. These cells highly express a homogeneous population of delta opioid receptor that couple to inhibitory Go/Gi proteins. Ligand affinity for the delta opioid receptor correlates with ligand EC50 values for stimulation of [35S]GTPgammaS binding.

摘要

用稳定转染大鼠δ阿片受体的C6胶质瘤细胞系(C6δ)来表征肽类和非肽类δ阿片配体的受体结合及G蛋白激活情况。[3H]纳曲吲哚和[3H]对氯苯甲酰-D-青霉胺2,D-青霉胺5-脑啡肽(DPDPE)的配体结合亲和力与在猴脑膜中观察到的相似。非肽类激动剂BW373U86和SNC80,以及肽类激动剂[D-丝氨酸2,L-亮氨酸5]脑啡肽-苏氨酸分别比基础水平最大程度地刺激[35S]GTPγS结合640%、654%和576%。肽类激动剂DPDPE和强啡肽II均刺激[35S]GTPγS结合375%。埃托啡、二丙诺啡、羟吗啡吲哚和7-螺茚满氧基吗啡在该试验中也是部分激动剂,尽管它们的效力低于强啡肽II。激动剂对[35S]GTPγS结合的刺激被百日咳毒素预处理完全阻断。δ-1和δ-2选择性拮抗剂7-亚苄基纳曲酮和纳曲吲哚的苯并呋喃类似物对克隆受体显示出高亲和力(分别为0.04和0.08 nM),并以相似的效力拮抗BW373U86和DPDPE对[35S]GTPγS结合的刺激。其他表明不存在受体亚型的证据包括以下发现:受体亚型选择性配体DPDPE和强啡肽II对[35S]GTPγS结合的刺激不是相加的。BW373U86、SNC80和DPDPE最大程度地抑制福斯高林刺激的腺苷酸环化酶。这些细胞高度表达与抑制性Go/Gi蛋白偶联的同质δ阿片受体群体。δ阿片受体的配体亲和力与刺激[35S]GTPγS结合的配体EC50值相关。

相似文献

1
Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.阿片类药物在稳定表达δ阿片受体的C6胶质瘤细胞系中的疗效。
J Pharmacol Exp Ther. 1997 Nov;283(2):501-10.
2
Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.δ阿片类物质对鸟苷-5'-O-(3-[35S]硫代)三磷酸与NG108-15细胞膜结合的调节作用:激动剂和反向激动剂效应的表征
J Pharmacol Exp Ther. 1997 Dec;283(3):1276-84.
3
Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.激动剂对克隆的人κ阿片受体的激活增强了[35S]GTPγS与膜的结合:配体效力和效能的测定。
J Pharmacol Exp Ther. 1997 Aug;282(2):676-84.
4
Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.δ阿片受体下调独立于功能性G蛋白,但依赖于激动剂效力。
J Pharmacol Exp Ther. 1998 Nov;287(2):625-32.
5
Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.在NG108 - 15神经母细胞瘤x胶质瘤杂交细胞中鉴定出三种与δ-阿片受体相互作用的不同鸟嘌呤核苷酸结合蛋白。
Mol Pharmacol. 1992 May;41(5):822-31.
6
Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.神经母细胞瘤NS20Y中δ阿片受体的特性:受体激活与神经母细胞瘤增殖
J Pharmacol Exp Ther. 1995 Jan;272(1):322-32.
7
BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.BW373U86:一种非肽类δ阿片受体激动剂,在大鼠脑膜和神经母细胞瘤细胞中具有新型受体 - G蛋白介导的作用。
Mol Pharmacol. 1993 Oct;44(4):827-34.
8
Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.生物碱和肽类阿片样激动剂在人神经母细胞瘤细胞系SK-N-BE中对G蛋白的差异性激活作用
Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):71-8.
9
Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.未分化人神经母细胞瘤SHSY5Y细胞中μ和δ阿片受体脱敏
J Pharmacol Exp Ther. 1994 Jul;270(1):177-84.
10
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.在表达μ阿片受体的C6胶质瘤细胞系中阿片类激动剂效能的表征
J Pharmacol Exp Ther. 1996 Sep;278(3):1121-7.

引用本文的文献

1
generation of dual-target compounds using artificial intelligence.利用人工智能生成双靶点化合物。
iScience. 2024 Dec 17;28(1):111526. doi: 10.1016/j.isci.2024.111526. eCollection 2025 Jan 17.
2
Predicting therapeutic and side effects from drug binding affinities to human proteome structures.从药物与人蛋白质组结构的结合亲和力预测治疗效果和副作用。
iScience. 2024 May 20;27(6):110032. doi: 10.1016/j.isci.2024.110032. eCollection 2024 Jun 21.
3
Pharmacological Properties of -Opioid Receptor-Mediated Behaviors: Agonist Efficacy and Receptor Reserve.
- 阿片受体介导行为的药理学特性:激动剂效能和受体储备。
J Pharmacol Exp Ther. 2020 Aug;374(2):319-330. doi: 10.1124/jpet.119.262717. Epub 2020 May 28.
4
Allosterism within Opioid- Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of Opioid Agonist Efficacy.外周感觉神经元中阿片类药物-阿片受体异源二聚体的变构作用:阿片类激动剂疗效的调节。
Mol Pharmacol. 2018 Apr;93(4):376-386. doi: 10.1124/mol.117.109975. Epub 2018 Feb 7.
5
Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.蛋白激酶Cε参与脊髓μ和δ阿片受体协同镇痛相互作用的配体要求。
Br J Pharmacol. 2015 Jan;172(2):642-53. doi: 10.1111/bph.12774. Epub 2014 Nov 24.
6
Characterization of BU09059: a novel potent selective κ-receptor antagonist.新型强效选择性κ受体拮抗剂BU09059的特性研究
ACS Chem Neurosci. 2014 Mar 19;5(3):177-84. doi: 10.1021/cn4001507. Epub 2014 Jan 28.
7
Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.UMB 425 的合成、建模和药理学评价,一种具有降低耐受性风险的混合 μ 激动剂/δ 拮抗剂阿片类镇痛药。
ACS Chem Neurosci. 2013 Sep 18;4(9):1256-66. doi: 10.1021/cn4000428. Epub 2013 Jun 11.
8
In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor.体内和体外鉴定纳曲吲哚衍生配体在 κ 阿片受体上的作用。
J Psychopharmacol. 2013 Feb;27(2):192-202. doi: 10.1177/0269881112464828. Epub 2012 Oct 31.
9
Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys.δ阿片类药物效能在恒河猴μ/δ阿片类药物相互作用中的决定作用。
Eur J Pharmacol. 2009 Jan 5;602(1):92-100. doi: 10.1016/j.ejphar.2008.11.004. Epub 2008 Nov 11.
10
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.δ阿片样物质配体的定量构象采样药效团:对生物活性至关重要的疏水部分的重新评估
J Med Chem. 2007 Apr 19;50(8):1799-809. doi: 10.1021/jm0612463. Epub 2007 Mar 17.